Issues with Tissues: Trends in Tissue-Engineered Products in Clinical Trials in the European Union

Tissue-engineered products (TEPs) consist of engineered cells or tissues produced to regenerate, repair, or replace a dysfunctional, diseased, or absent human tissue. TEPs make up <5% of all advanced therapeutic medicinal products (ATMPs) in clinical trials and received 5.1% of ATMP-designated fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Joyce, Kieran, Buljovcic, Zaklina, Rosic, Goran, Kaszkin-Bettag, Marietta, Pandit, Abhay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940800/
https://www.ncbi.nlm.nih.gov/pubmed/36062927
http://dx.doi.org/10.1089/ten.teb.2022.0094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940800/
https://www.ncbi.nlm.nih.gov/pubmed/36062927
http://dx.doi.org/10.1089/ten.teb.2022.0094

Ejemplares similares